Block listing Interim Review

Hikma Pharmaceuticals Plc

02 October 2023

Hikma Pharmaceuticals PLC

Block Listing Six Monthly Return

Date: 2 October 2023

Name of applicant:	Hikma Pharmaceuticals PLC
Name of scheme:	Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans")
Period of return	From: 1 April 2023	To:	30 September 2023
Balance of unallotted securities under scheme(s) from previous return:	The Plans: 1,497,913 Ordinary Shares of 10 pence
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):	The Plans: 0 Ordinary Shares of 10 pence
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):	2018 MIP: 438 Ordinary Shares of 10 pence EIP: 378,765 Ordinary Shares of 10 pence
Equals: Balance under scheme(s) not yet issued/allotted at end of period:	The Plans: 1,118,710 Ordinary Shares of 10 pence

Name of contact:	Hussein Arkhagha
Telephone number of contact:	+44(0)20 7399 2760

LEI: 549300BNS685UXH4JI75

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

Companies

Hikma Pharmaceuticals (HIK)

Full Archive

UK 100

Latest directors dealings

All directors dealings today